Back to Search
Start Over
Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata.
- Source :
-
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2022 Oct 12; Vol. 20 (1), pp. 88. Date of Electronic Publication: 2022 Oct 12. - Publication Year :
- 2022
-
Abstract
- Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare chronic inflammatory disease with osteoarticular and cutaneous involvements as its main manifestations. Acne conglobata as a severe acne form may affect adolescent patients. Tumor necrosis factor inhibitors are usually used as a second-line therapy for refractory SAPHO syndrome and has been reported to treat acne conglobata successfully. We herein report three cases of adolescent patients with SAPHO syndrome associated with acne conglobata who were successfully treated with TNFi therapy.<br /> (© 2022. The Author(s).)
Details
- Language :
- English
- ISSN :
- 1546-0096
- Volume :
- 20
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Pediatric rheumatology online journal
- Publication Type :
- Editorial & Opinion
- Accession number :
- 36224598
- Full Text :
- https://doi.org/10.1186/s12969-022-00749-9